Jefferies Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $107M | Buy |
914,200
+697,700
| +322% | +$86.6M | 0.89% | 16 |
|
|
2022
Q2 | $25.5M | Sell |
216,500
-22,700
| -9% | -$2.69M | 0.21% | 71 |
|
|
2022
Q1 | $31.2M | Sell |
239,200
-16,700
| -7% | -$2.18M | 0.2% | 83 |
|
|
2021
Q4 | $39.1M | Buy |
255,900
+39,700
| +18% | +$6.15M | 0.23% | 65 |
|
|
2021
Q3 | $35M | Sell |
216,200
-215,800
| -50% | -$36.3M | 0.25% | 60 |
|
|
2021
Q2 | $70.7M | Buy |
432,000
+37,000
| +9% | +$5.7M | 0.45% | 37 |
|
|
2021
Q1 | $59.5M | Sell |
395,000
-931,200
| -70% | -$148M | 0.52% | 27 |
|
|
2020
Q4 | $201M | Buy |
1,326,200
+631,100
| +91% | +$90.2M | 1.58% | 8 |
|
|
2020
Q3 | $94.1M | Sell |
695,100
-485,300
| -41% | -$65.8M | 1.04% | 11 |
|
|
2020
Q2 | $161K | Buy |
1,180,400
+871,000
| +282% | +$111M | 1.9% | 7 |
|
|
2020
Q1 | $33.3M | Buy |
309,400
+78,100
| +34% | +$8.99M | 0.37% | 29 |
|
|
2019
Q4 | $27.9M | Sell |
231,300
-554,300
| -71% | -$61.8M | 0.22% | 69 |
|
|
2019
Q3 | $78.2M | Sell |
785,600
-71,200
| -8% | -$7.45M | 0.61% | 8 |
|
|
2019
Q2 | $93.5M | Buy |
856,800
+373,300
| +77% | +$39.7M | 0.68% | 12 |
|
|
2019
Q1 | $54.1M | Sell |
483,500
-162,800
| -25% | -$17.9M | 0.44% | 22 |
|
|
2018
Q4 | $62.3M | Buy |
646,300
+508,800
| +370% | +$54M | 0.51% | 19 |
|
|
2018
Q3 | $16.8M | Sell |
137,500
-26,500
| -16% | -$3.12M | 0.11% | 161 |
|
|
2018
Q2 | $18M | Sell |
164,000
-638,600
| -80% | -$68.3M | 0.1% | 127 |
|
|
2018
Q1 | $85.7M | Buy |
802,600
+420,100
| +110% | +$46.6M | 0.46% | 25 |
|
|
2017
Q4 | $40.8M | Buy |
382,500
+381,000
| +25,400% | +$40.7M | 0.19% | 65 |
|
|
2017
Q3 | $167K | Buy |
+1,500
| New | +$160K | ﹤0.01% | 2106 |
|
|
2016
Q4 | – | Sell |
-194,400
| Closed | -$18.8M | – | 2323 |
|
|
2016
Q3 | $18.8M | Buy |
+194,400
| New | +$18.5M | 0.1% | 162 |
|
|
2016
Q2 | – | Sell |
-159,600
| Closed | -$13.9M | – | 2268 |
|
|
2016
Q1 | $13.9M | Buy |
+159,600
| New | +$14.3M | 0.08% | 185 |
|
|
2015
Q4 | – | Sell |
-333,000
| Closed | -$33.7M | – | 2400 |
|
|
2015
Q3 | $33.7M | Sell |
333,000
-118,500
| -26% | -$14.2M | 0.19% | 90 |
|
|
2015
Q2 | $55.5M | Buy |
451,500
+101,100
| +29% | +$12.1M | 0.29% | 58 |
|
|
2015
Q1 | $40.1M | Buy |
350,400
+113,100
| +48% | +$12.5M | 0.22% | 62 |
|
|
2014
Q4 | $24M | Buy |
+237,300
| New | +$23.1M | 0.14% | 126 |
|
|
2014
Q3 | – | Sell |
-366,000
| Closed | -$31.4M | – | 2259 |
|
|
2014
Q2 | $31.4M | Buy |
+366,000
| New | +$28.8M | 0.27% | 73 |
|
Other funds holding IBB
CB
Jefferies Group's IBB Position: Q3 2022 in Review
Jefferies Group increased its iShares Biotechnology ETF (IBB) stake by 151,333% in Q3 2022, buying an estimated $21.2M and bringing the position to 171,119 shares worth $20M. The position accounts for 0.17% of the portfolio, ranked #96.
Jefferies Group first reported a position in IBB in Q2 2014 and has held it in 30 quarters since. The position peaked at $38.7M in Q1 2018. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.
- Jefferies Group held 171,119 shares of iShares Biotechnology ETF worth $20M as of Q3 2022.
- Jefferies Group bought 171,006 iShares Biotechnology ETF shares in Q3 2022, an estimated $21.2M.
- iShares Biotechnology ETF made up 0.17% of Jefferies Group's portfolio in Q3 2022, its #96 holding.
- Jefferies Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 30 quarters since.
- Jefferies Group's iShares Biotechnology ETF position peaked at $38.7M in Q1 2018.
- 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.